Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival. - Wikidata - awgldk - TriplyDB

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.

http://www.wikidata.org/entity/Q30299957

about

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.Long-term outcomes of helper peptide vaccination for metastatic melanoma.A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies.Advances in Immunotherapy for Melanoma: A Comprehensive Review.Vaccines targeting helper T cells for cancer immunotherapy.Immunotherapy of cancers comes of age.

P2860

Q26782583-15203573-D7B9-4EF5-849C-66E46B52384D Q30278070-EAFC5A3E-71A8-429A-936B-8746EACF4789 Q30278874-ADEFDBDB-8271-4E6D-BF39-2BBC1964EEBF Q33849643-9979C18E-C232-47CA-BBFD-570080C047C8 Q38372054-F036A497-5CB1-4155-A207-C64C6DEE88E2 Q38636521-409D968A-E53E-4122-B0C6-C02D2BE4E590 Q38649958-AD2D05D8-747F-462A-A5DA-ABB122E4C1E2 Q40099075-DAFACA8F-F72A-43F9-BD88-1FBB1218EA11

P2860

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.

http://www.wikidata.org/entity/Q30299957

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Vaccination with Melanoma Help ...... ith Improved Overall Survival.

@ast

Vaccination with Melanoma Help ...... ith Improved Overall Survival.

@en

type

label

Vaccination with Melanoma Help ...... ith Improved Overall Survival.

@ast

Vaccination with Melanoma Help ...... ith Improved Overall Survival.

@en

prefLabel

Vaccination with Melanoma Help ...... ith Improved Overall Survival.

@ast

Vaccination with Melanoma Help ...... ith Improved Overall Survival.

@en

P1433

Q30299957-95CB369B-A06E-4373-8547-CC20A7675FDE

P1476

Q30299957-7AF70D67-DE83-48E0-B6E0-7C7E2579A986

P2093

Q30299957-0478F030-284B-4342-84EA-6A2ACA384A0E

Q30299957-63E2D47D-BDBB-4AAA-A905-903BE985D472

Q30299957-F7AF6733-82DA-4B8B-ABE1-1C979DBEF126

P2860

Q30299957-0065680C-0E39-43DC-8D24-F0B2991F8BD9

Q30299957-08920D41-D269-4959-A963-4E6EA61F4849

Q30299957-0C5B398B-B29F-4748-9B1F-B2E98886B803

Q30299957-0D06F369-A432-4E10-AAE3-6FDCC04D7840

Q30299957-135A8C9A-30F5-48C9-8FC4-598B806C610F

Q30299957-21AF084B-ADE1-46F8-8FED-BCE12AE171D3

Q30299957-246BA041-D1FC-4918-9B5B-20E8A0F7EEAA

Q30299957-2E9CB578-FE69-491F-8A86-48FE6A5493B9

Q30299957-579DBB8D-35C5-4E9B-A0F8-865E8EEBC5A3

Q30299957-64CA607B-9115-43CD-A311-5B46FB0DB71D

P304

Q30299957-F8B4820C-2A06-4FEF-A192-7884D47C7C6E

P31

Q30299957-6485219A-9997-472C-9D91-B06AED8B0018

P356

Q30299957-63EE1CFE-BBCA-4EB5-8933-34C89E3146CD

P407

Q30299957-59ACE37C-C8D8-43F6-8A57-D7BBECC0C646

P433

Q30299957-5588EB9C-F6F9-4209-BBE3-2C546C13EB52

P478

Q30299957-2AD4F064-82A8-43E7-95E9-4BDE141FCD85

P50

Q30299957-3DEBC8CD-BB1E-4CF8-B472-CC53F212DA86

Q30299957-EC04F8AA-81C9-430F-AF78-53C5FD0F9F6C

P577

Q30299957-E85924AF-4580-49BD-812B-456B043F1A95

P698

Q30299957-455A7E7B-1B18-4336-A21B-BF3D3B97C845

P921

Q30299957-B1FAB9CC-4F1F-4DC6-83B2-35B8E85EE64A

P932

Q30299957-CB48AF57-7DEE-4444-94E9-D3B96CD4CE26

P356

1078-0432.CCR-15-0233

P1433

Clinical Cancer Research

P1476

Vaccination with Melanoma Help ...... ith Improved Overall Survival.

@en

P2093

Caroline M Reed

http://www.w3.org/2001/XMLSchema#string

Nicole D Cresce

http://www.w3.org/2001/XMLSchema#string

Walter C Olson

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of FcRn in Antigen Presentation

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes

A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)

Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma

The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens.

Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes

NY-ESO-1: review of an immunogenic tumor antigen.

Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein.

P304

3879-3887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-15-0233

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Ileana S Mauldin

Craig Slingluff

P577

2015-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25967144

http://www.w3.org/2001/XMLSchema#string

P921

P932

4558239

http://www.w3.org/2001/XMLSchema#string